Skip to main content

Table 2 Description of the 8 scenarios simulated

From: The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study

Scenario

Time to diagnosis (mean)

Time to linkage to care (mean)

Loss to follow-up rate (%/y)

Treatment eligibility

Treatment rate among eligible PWID

%SVR

1 (reference)

2 y

1.7 y

10.2%/y

F0 → F4

5%/y

81%

2

0.5 y

1.7 y

10.2%/y

F0 → F4

5%/y

81%

3

2 y

0.5y

5%/y

F0 → F4

5%/y

81%

4

2 y

1.7 y

10.2%/y

F0 → F4

5%/y

90%

5

2 y

1.7 y

10.2%/y

F0 → F4

10%/y

81%

6

2 y

1.7 y

10.2%/y

F0 → F4

20%/y

81%

7

0.5 y

0.5 y

5%/y

F0 → F4

20%/y

90%

8

0.5 y

0.5 y

5%/y

F2 → F4

100%/y

90%

  1. PWID People who inject drugs, SVR sustained virological response